Crystal Sung

High antibody titer in an adult with Pompe disease affects treatment with alglucosidase alfa

Juna M. de Vries, Nadine A. M. E. van der Beek, Marian A. Kroos et al. · Molecular Genetics and Metabolism · 2010 · 104 citations

Life Sciences, Immunology, Pathology +11

A retrospective analysis of the potential impact of IgG antibodies to agalsidase β on efficacy during enzyme replacement therapy for Fabry disease

Bernard Bénichou, Sunita Goyal, Crystal Sung et al. · Molecular Genetics and Metabolism · 2008 · 102 citations

Life Sciences, Biochemistry, Enzymology +4

Alemtuzumab can be Incorporated Into Front-Line Therapy of Adult Acute Lymphoblastic Leukemia (ALL): Final Phase I Results of a Cancer and Leukemia Group B Study (CALGB 10102).

Wendy Stock, Ben L. Sanford, Gerard Lozanski et al. · Blood · 2009 · 64 citations

Pharmacy, Oncology, Pharmacotherapy +12

Liquid Chromatography–Tandem Mass Spectrometry Quantification of Globotriaosylceramide in Plasma for Long-Term Monitoring of Fabry Patients Treated with Enzyme Replacement Therapy

Thomas P. Roddy, Bryant C. Nelson, Crystal Sung et al. · Clinical Chemistry · 2004 · 35 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

An immune tolerance approach using transient low-dose methotrexate in the ERT-naïve setting of patients treated with a therapeutic protein: experience in infantile-onset Pompe disease

Zoheb B. Kazi, Ankit K. Desai, R. Bradley Troxler et al. · Genetics in Medicine · 2018 · 34 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +13